Assessing Circulating Tumor Cell as a Biomarker for Prostate Cancer Detection in Patients With Gray Zone PSA Level
Condition(s):Prostate CancerLast Updated:April 5, 2018Unknown status
Hide Studies Not Open or Pending
Condition(s):Prostate CancerLast Updated:April 5, 2018Unknown status
Condition(s):Menopause; Elevated Blood Pressure; Hypertension; Endothelial DysfunctionLast Updated:September 14, 2022Completed
Condition(s):Postpartum CVD Risk in Women With Previous Preeclampsia.Last Updated:January 6, 2015Unknown status
Condition(s):Aortic Stenosis; Hypo-attenuated Leaflet Thickening; Bioprosthetic Valve DegenerationLast Updated:November 10, 2021Recruiting
Condition(s):Amyotrophic Lateral Sclerosis (ALS)Last Updated:March 15, 2023Recruiting
Condition(s):Non-Hodgkin LymphomaLast Updated:December 7, 2023Not yet recruiting
Condition(s):BiomarkerLast Updated:December 21, 2023Active, not recruiting
Condition(s):Hidradenitis Suppurativa; Dermatitis, AtopicLast Updated:April 13, 2021Completed
Condition(s):Colorectal CancerLast Updated:August 21, 2020Unknown status
Condition(s):Ischemic Stroke; AtherosclerosisLast Updated:October 2, 2023Not yet recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.